Immunotherapy has emerged as an eminent and effective modality in the treatment of
cancer. However, current cancer immunotherapies lack spatial and temporal control …

Cancer immunotherapy, which reprograms a patient's own immune system to eradicate
cancer cells, has been demonstrated as a promising therapeutic strategy clinically. Immune …

Colon and rectal cancers are the most common kinds of cancer globally. Colon cancer is
more prevalent in men than in women. Early detection increases the likelihood of survival …

Malignant bone tumors, which are difficult to treat with current clinical strategies, originate
from bone tissues and can be classified into primary and secondary types. Due to the …

Over the past decade, immunotherapy aiming to activate an effective antitumor immune
response has ushered in a new era of cancer treatment. However, the efficacy of cancer …

Cancer vaccine efficacy is limited by the immunosuppressive nature of the tumor
microenvironment created by inflammation, immune inhibitory factors, and regulatory T cells …

Cancer represents the leading global driver of death and is recognized as a critical obstacle
to increasing life expectancy. In recent years, with the development of precision medicine …

Chiral carbon dots (CCDs) can be widely used in various fields such as chiral recognition,
chiral catalysis and biomedicine because of their unique optical properties, low toxicity and …

Despite recent advancements in cancer treatment, this disease still poses a serious threat to
public health. Vaccines play an important role in preventing illness by preparing the body's …

New therapeutic strategies are required in cancer therapy. Considering the prominent role of
tumor-associated macrophages (TAMs) in the development and progression of cancer, the …